The side effects of pulmonary cancer are too great. Can we not do it?

The side effects of pulmonary cancer chemotherapy do have a significant impact on the quality of life of patients, but a combination of factors is needed in deciding whether to carry out chemotherapy. Here’s what we’re going to do about “the side effects of pulmonary cancer.” Detailed discussion of this issue.The need for chemotherapy and side effectschemotherapy is an important component of lung cancer treatment, especially for patients with advanced or transferred lung cancer. It can reduce tumours, control conditions and extend life. However, the side effects of chemotherapy do exist, including nausea, vomiting, hair loss, bone marrow inhibition, fatigue, oral ulcer, heart and kidney damage, which may seriously affect the quality of life of patients.Can we not do chemo?Individual differences: each patient ‘ s condition, state of health, age and response to chemotherapy are different. Some patients may be more resilient to the side effects of chemotherapy, while others may have severe side effects.Tumour type and period: lung cancer is divided into small-cell and non-small-cell lung cancer, with different treatment strategies. As small-cell lung cancer is usually more sensitive to chemotherapy, chemotherapy is the main treatment. Treatment for lung cancer, rather than small cell cancer, is more selective, including surgery, treatment and target-oriented treatment.Treatment target: chemotherapy may be necessary if the treatment target is a cure. However, if the goal is to mitigate symptoms and improve the quality of life, alternative treatment may need to be considered.Alternative treatmentTarget treatment: Target treatment may be an effective option for certain patients with genetic mutations with lung cancer. Targeted drugs are targeted at specific molecules of cancer cells, with often less side effects than chemotherapy.Immunotherapy: Immunotherapy can be an effective treatment for some patients by attacking their own immune system.(a) Treatment: In cases of terminal or non-operative lung cancer, it can be used to reduce tumours or symptoms.Supportive treatment, including nutritional support, counselling, pain management, etc., aimed at improving the quality of life of patients.Decision-making processThe doctor recommends that the patient communicate fully with the doctor about the potential benefits and risks of chemotherapy and whether there are other feasible treatment options.Patient’s will: The patient’s personal will and tolerance for side effects are also important factors in decision-making. Patients have the right to choose according to their own values and quality of life requirements.Comprehensive assessment: Patients and doctors should make the most appropriate treatment decisions, taking into account the biological characteristics of the tumor, the overall condition of the patient, the aims of treatment and the quality of life.ConclusionsThe side effects of pulmonary cancer chemotherapy are indeed an important factor to consider, but not the only one to decide whether or not to undergo chemotherapy. In some cases, chemotherapy may be necessary if its potential benefits outweigh the risk or if there are no other effective treatment options. However, if there are too many side effects, or if there are other treatments that are equally effective, consideration may be given to reducing the doses of chemotherapy or seeking alternative treatment. Ultimately, treatment decisions should be based on adequate communication and joint decision-making between patients and doctors.